Eaton Corporation plc vs Immunovant Inc. Common Stock — how do they compare? Eaton Corporation plc trades at $429.46 (market cap $164.88B), while Immunovant Inc. Common Stock trades at $30.53 (market cap $6.25B). The key difference: Eaton Corporation plc is far larger — about 26.4× Immunovant Inc. Common Stock's market cap, and Eaton Corporation plc pays a 1.04% dividend while Immunovant Inc. Common Stock pays none. Which is the better fit depends on your goals — on Pluang, investors hold Eaton Corporation plc for 31 Days and Immunovant Inc. Common Stock for 0 Days on average.
| ETN | IMVT | |
|---|---|---|
Market Cap | $164.88B | $6.25B |
Volume | 2,535,086 | 1,755,411 |
Sector | Industrials | Health |
52-Week High | $459.96 | $44.96 |
52-Week Low | $315.82 | $17.03 |
Typical Hold Time | 31 Days | 0 Days |
Enterprise Value | $185.51B | $5.35B |
Dividend Yield | 1.04% | — |
Signals from Pluang's Aura AI — not financial advice
Eaton Corporation (ETN) trades at $424.64, down 1.55% today, with a bearish technical signal despite strong fundamentals. The company has consistently beaten earnings estimates in recent quarters, with Q3 2026 results pending. ETN maintains robust profitability with 12.75% net income margin and 19.71% ROE, supported by strategic acquisitions in data center and aerospace markets. Recent news highlights growing investor attention and positive analyst coverage.
ETN presents a compelling growth story driven by data center demand and grid modernization, with 70% analyst buy ratings and a $502.38 consensus price target suggesting 18% upside. However, elevated valuation multiples (P/E 43.23) and bearish technical indicators warrant caution. Key risks include execution of acquisition strategy and competitive pressures in the electronics manufacturing sector.
No Aura AI signal available yet.
Trailing returns across standard periods
What Pluang investors did over the last 30 days
Latest headlines on both assets
Eaton is a global power management company providing energy-efficient solutions for electrical, aerospace, and industrial sectors. It focuses on improving sustainability through intelligent power technology.
Read more on ETN →Immunovant is a clinical-stage immunology company developing therapies for autoimmune diseases. Its pipeline includes anti-FcRn antibody candidates designed for subcutaneous administration.
Read more on IMVT →